Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Assets Average (2016 - 2025)

Myriad Genetics (MYGN) has disclosed Assets Average for 15 consecutive years, with $717.4 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 31.97% to $717.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $717.4 million through Dec 2025, down 31.97% year-over-year, with the annual reading at $867.1 million for FY2025, 20.23% down from the prior year.
  • Assets Average for Q4 2025 was $717.4 million at Myriad Genetics, up from $702.7 million in the prior quarter.
  • The five-year high for Assets Average was $1.4 billion in Q1 2021, with the low at $702.7 million in Q3 2025.
  • Average Assets Average over 5 years is $1.1 billion, with a median of $1.2 billion recorded in 2023.
  • The sharpest move saw Assets Average decreased 3.55% in 2023, then tumbled 35.13% in 2025.
  • Over 5 years, Assets Average stood at $1.3 billion in 2021, then fell by 9.26% to $1.2 billion in 2022, then decreased by 4.77% to $1.1 billion in 2023, then decreased by 8.13% to $1.1 billion in 2024, then plummeted by 31.97% to $717.4 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $717.4 million, $702.7 million, and $841.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.